BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and biological evaluation of peptide derivatives of L-dopa as anti-parkinsonian agents. 2013

Tao Zhou, and Robert C Hider, and Peter Jenner, and Bruce Campbell, and Christopher J Hobbs, and Sarah Rose, and Mark Jairaj, and Kayhan A Tayarani-Binazir, and Alexander Syme
School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, Zhejiang 310035, PR China. taozhou@zjgsu.edu.cn

A series of dipeptide derivatives of L-dopa were synthesized and investigated for their pharmacological activity using the unilaterally 6-hydroxydopamine (6-OHDA)-lesioned rat as an experimental model of Parkinson's disease. Among them, (S)-isopropyl 2-(2-amino-2-methylpropanamido)-3-(3,4-dihydroxyphenyl)propanoate (4 g) was found to be the most active compound, with 106% AUC activity and 149% peak activity of L-dopa after oral administration.

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D004151 Dipeptides Peptides composed of two amino acid units. Dipeptide
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000978 Antiparkinson Agents Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. Antiparkinson Drugs,Antiparkinsonian Agents,Antiparkinsonians,Agents, Antiparkinson,Agents, Antiparkinsonian,Drugs, Antiparkinson
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Tao Zhou, and Robert C Hider, and Peter Jenner, and Bruce Campbell, and Christopher J Hobbs, and Sarah Rose, and Mark Jairaj, and Kayhan A Tayarani-Binazir, and Alexander Syme
Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson's Disease Agents.
June 2019, Biomolecules,
Tao Zhou, and Robert C Hider, and Peter Jenner, and Bruce Campbell, and Christopher J Hobbs, and Sarah Rose, and Mark Jairaj, and Kayhan A Tayarani-Binazir, and Alexander Syme
Design, synthesis, and biological evaluation of morpholinopyrimidine derivatives as anti-inflammatory agents.
June 2023, RSC advances,
Tao Zhou, and Robert C Hider, and Peter Jenner, and Bruce Campbell, and Christopher J Hobbs, and Sarah Rose, and Mark Jairaj, and Kayhan A Tayarani-Binazir, and Alexander Syme
Design, synthesis, and biological evaluation of novel arylcarboxamide derivatives as anti-tubercular agents.
February 2020, RSC advances,
Tao Zhou, and Robert C Hider, and Peter Jenner, and Bruce Campbell, and Christopher J Hobbs, and Sarah Rose, and Mark Jairaj, and Kayhan A Tayarani-Binazir, and Alexander Syme
Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents.
January 2015, European journal of medicinal chemistry,
Tao Zhou, and Robert C Hider, and Peter Jenner, and Bruce Campbell, and Christopher J Hobbs, and Sarah Rose, and Mark Jairaj, and Kayhan A Tayarani-Binazir, and Alexander Syme
Design, Synthesis and Biological Evaluation of Ligustrazine-Flavonoid Derivatives as Potential Anti-Tumor Agents.
August 2018, Molecules (Basel, Switzerland),
Tao Zhou, and Robert C Hider, and Peter Jenner, and Bruce Campbell, and Christopher J Hobbs, and Sarah Rose, and Mark Jairaj, and Kayhan A Tayarani-Binazir, and Alexander Syme
Design, Synthesis and Preliminary Biological Evaluation of Benzylsulfone Coumarin Derivatives as Anti-Cancer Agents.
November 2019, Molecules (Basel, Switzerland),
Tao Zhou, and Robert C Hider, and Peter Jenner, and Bruce Campbell, and Christopher J Hobbs, and Sarah Rose, and Mark Jairaj, and Kayhan A Tayarani-Binazir, and Alexander Syme
Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents.
April 2004, Bioorganic & medicinal chemistry,
Tao Zhou, and Robert C Hider, and Peter Jenner, and Bruce Campbell, and Christopher J Hobbs, and Sarah Rose, and Mark Jairaj, and Kayhan A Tayarani-Binazir, and Alexander Syme
Design, Synthesis, and Biological Evaluation of Itaconic Acid Derivatives as Potential Anti-Influenza Agents.
March 2019, Journal of medicinal chemistry,
Tao Zhou, and Robert C Hider, and Peter Jenner, and Bruce Campbell, and Christopher J Hobbs, and Sarah Rose, and Mark Jairaj, and Kayhan A Tayarani-Binazir, and Alexander Syme
Design, Synthesis and Biological Evaluation of Thiohydantoin Derivatives as Novel Anti-prostate Cancer Agents.
January 2016, Anti-cancer agents in medicinal chemistry,
Tao Zhou, and Robert C Hider, and Peter Jenner, and Bruce Campbell, and Christopher J Hobbs, and Sarah Rose, and Mark Jairaj, and Kayhan A Tayarani-Binazir, and Alexander Syme
Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents.
August 2012, Journal of enzyme inhibition and medicinal chemistry,
Copied contents to your clipboard!